Open AccessImmunohistochemistry biomarker TP53 expression predicts the survival of thymomas
Author(s) -
Dongliang Bian,
Liting Zhao,
Zhang Xue-lin,
Fanzhen Lv,
Zhenghong Zhu,
Hui Qiu,
Huibiao Zhang
Publication year - 2020
Publication title -
gland surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 22
eISSN - 2227-8575
pISSN - 2227-684X
DOI - 10.21037/gs.2020.03.01
Subject(s) - medicine , immunohistochemistry , biomarker , thymoma , pathological , hazard ratio , univariate analysis , oncology , stage (stratigraphy) , multivariate analysis , perioperative , pathology , surgery , confidence interval , paleontology , biochemistry , chemistry , biology
Thymomas are rare malignancies. Thymectomy is the optimal therapy which could prolong the survival of patients. However, prognostic factors of thymomas are not clear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom